Using focused ultrasound to help treat anxiety disorders
Official title: Modulating Escape in the Anxiety Disorder Spectrum: Targeting the Direct Neural Mediator Using Transcranial Focused Ultrasound
Run by Medical University of South Carolina · NCT06273904 · Data updated 2026-11-12
This study is testing whether focused ultrasound can help people with anxiety by changing how their brain works during emotional tasks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | May 20, 2024 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT06273904 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-65 who meet the criteria for an anxiety disorder and are currently seeking mental health treatment.
✕Probably not a fit
Patients with severe substance use disorders, psychotic disorders, or neurological conditions that contraindicate brain stimulation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of transcranial focused ultrasound (tFUS) as a non-invasive method to modulate brain activity in individuals with anxiety disorders. Participants will undergo three visits where they will complete interviews and tasks involving emotional stimuli while their brain activity is monitored using MRI. The primary goal is to assess whether tFUS can effectively target subcortical brain areas associated with escape and avoidance behaviors, potentially improving treatment outcomes for those struggling with anxiety. The study aims to provide insights into the efficacy of tFUS as a precursor to traditional therapeutic interventions.
Why it matters
Potential benefit: If successful, this approach could offer a novel, non-invasive treatment option for individuals with anxiety disorders, enhancing their coping mechanisms and treatment retention.
How similar studies have gone: While the use of tFUS is a relatively novel approach, preliminary studies suggest potential efficacy in modulating brain activity, though this specific application for anxiety disorders is less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-65 y.o. * Meets criteria for an anxiety disorder (Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Specific Phobia), posttraumatic stress disorder, obsessive-compulsive disorder, or current adjustment disorder with anxiety * Is currently seeking mental health treatment * Is able to read consent document and provide informed consent. * English is a first or primary fluent language. Exclusion Criteria: * Current alcohol or substance use disorder of more than mild severity (as defined by the Diagnostic and Statistical Manual (DSM)-5 and determined using standardized self-report instruments) * Lifetime diagnosis of psychotic disorder or bipolar mania * Presence of neurological disorder that contraindicates brain stimulation or neurophysiological recording: Seizure disorder * Lifetime history of traumatic brain injury with loss of consciousness * Neurodegenerative disorder (e.g., Alzheimer's Disease, Parkinson's Disease, Frontotemporal Dementia) * Presence of other medical disorder that would make it too uncomfortable to sit or lie still for long recording periods * Presence of standard contraindications for magnetic resonance imaging * Metal in the body * Currently pregnant * Claustrophobia * Significant sensitivity to noise * Medical conditions or treatments that lower seizure threshold * History of severe brain injury * History of seizures/ epilepsy * Currently taking anticholinergic mediation, neuroleptic medication, or sedative/ hypnotic medication Note: selective serotonin re-uptake inhibitors (SSRIs), cholinesterase inhibitors or N-methyl-D-aspartate (NMDA) receptor antagonists are allowed if patient has been on a stable regimen of four weeks prior to enrollment * Currently taking chronic opiate medications or substances * Currently taking naltrexone
Where it's running
-
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Christopher Sege, PhD — Medical University of South Carolina
- Study coordinator: Christopher T Sege, PhD
- Email: sege@musc.edu
- Phone: (843) 501-1718
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
See if personalized CBM-I can help anxious kids ages 10–17
Aimed at youth with Generalized, Separation, or Social Anxiety, the study tests a personalized cognitive bias modification for interpretation (CBM-I) to see if it reduces threat-focused thinking and anxiety.
-
Expectancy Focused Exposure for Anxiety Disorders
We test whether Expectancy Focused Exposure helps reduce anxiety symptoms and prevent fear from coming back better than Anxiety Focused Exposure in adults with anxiety disorders.
-
Does extra family income improve child mental health and brain biology in low-income families?
This study tests whether three years of extra income for parents can improve their child’s mental health and neuroimmune function.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
-
AI-guided cognitive behavioral therapy for depression and anxiety
This program will try an AI-guided online CBT to see if it helps adults with mild depression or anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.